FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

13549911000001105: Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1848041000001113 Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1848051000001111 Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Is a Gliclazide 30mg modified-release tablets true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Is a Gliclazide 30mg m/r tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Modified-release oral tablet false Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has specific active ingredient Gliclazide true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Is a Gliclazide 30mg modified-release tablets false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Is pack of False Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Is pack of False Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) 56 tablet 4 x 14 tablets Has AMP True Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier
Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) 28 tablet 2 x 14 tablets Has AMP True Gliclazide 30mg modified-release tablets (Kent Pharma (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start